Sinovac Biotech
Presença
Sinovac Biotech é uma empresa listada sob o símbolo SVA (CN).
Executivos
Veja o organograma con seus 11 executivos principais
Biografias mais buscadas da Sinovac Biotech
- Weidong Yin, Chairman of the Board, President and Chief Executive ...
- Kenneth Lee, Independent Director
- Yuk Lam Lo, Independent Director
Criar um alerta
para seguir os movimentos de executivos da Sinovac Biotech.
Biotecnologia
Sinovac Biotech possui 2.281 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Endeavor BioMedicines acaba de anunciar uma arrecadação de fundos de 132 milhões de dólares. (publicado em 25 de abril de 2024).
- Metsera acaba de anunciar uma arrecadação de fundos de 290 milhões de dólares. (publicado em 23 de abril de 2024).
- Histogen has filed for bankruptcy protection (publicado em 19 de abril de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Sinovac Biotech
- SINOVAC and Bogotá Present BogotáBio, Colombia's First Public Vaccine Manufacturing Facility-SINOVAC: Supply Vaccines to Eliminate Human Diseases
- Chilean President Boric Meets with SINOVAC Chairman and CEO Weidong Yin-SINOVAC: Supply Vaccines to Eliminate Human Diseases
- Turkish Ambassador to China Visits SINOVAC in Beijing-SINOVAC: Supply Vaccines to Eliminate Human Diseases
- SINOVAC Receives Visits from Bogotá Mayor and Colombian Ambassador to China in Beijing-SINOVAC: Supply Vaccines to Eliminate Human Diseases
- SINOVAC Launches Its First Overseas Jointly Invested Vaccine Production Plant in Türkiye-SINOVAC: Supply Vaccines to Eliminate Human Diseases
- SINOVAC's Vital Role in the Belt and Road Initiative: A Lifeline in the Fight Against Infectious Diseases-SINOVAC: Supply Vaccines to Eliminate Human Diseases
- SINOVAC Chairman Meets with Chilean President to Foster Bilateral Cooperation-SINOVAC: Supply Vaccines to Eliminate Human Diseases
- CPHI Barcelona 2023: SINOVAC Showcases Comprehensive Product Portfolio-SINOVAC: Supply Vaccines to Eliminate Human Diseases
- SINOVAC Begins Phase I Trials of Bivalent Enterovirus Vaccine-SINOVAC: Supply Vaccines to Eliminate Human Diseases
- Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer-SINOVAC: Supply Vaccines to Eliminate Human Diseases
- View more press releases Close
Redes sociais sobre Sinovac Biotech
- Sinovac Biotech na Wikipedia, Google News e Yahoo Finance
- Sinovac Biotech na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Weidong Yin 
Ligue para a Sinovac Biotech em +86 108...
